Antibody evolution could guide HIV vaccine development

Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.

http://www.biologynews.net/archives/2013/04/04/antibody_evolution_could_guide_hiv_vaccine_development.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+biologynews%2Fheadlines+%28Biology+News+Net%29